• Lan Sun
  • Rui Zhao
  • Xiu-Ying Yang
  • Guan-Hua DuEmail author


Daphnetin is mainly extracted from Yu Ruixiang Changbai Daphne. Daphnetin has the pharmacological effects on cardiovascular system, central nervous system, and immune system, which made it mainly used for treatment of coronary heart disease, occlusive vascular disease, and Buerger’s disease in clinical. In the 1970s, the artificial synthesis of daphnetin, which promoted R&D, makes it a landmark of new drug discovery in China. Daphnetin has extensive pharmacological effects, but pharmacological researches are still based on animal experiments. Pharmacodynamics, pharmacokinetics, and clinical research for other indications are needed as soon as possible.


Daphnetin Changbai daphne Coronary heart disease 


  1. 1.
    Jinjun S, Di Liuqing ZX, et al. Determination of equilibrium solubility and apparent oil/water partition coefficient of Daphnetin. J Nanjing Univ Tradit Chin Med. 2011;27(5):449–50.Google Scholar
  2. 2.
    Plant groups from Traditional Chinese medicine research laboratory, Jilin institute of Chinese medicine. Study of effective component from Changbai daphne – the separation and identification of daphnetin. J Tradit Chin Med. 1977; (4):15–18.Google Scholar
  3. 3.
    Liu Guoqin, Wang Qiujuan, Yang Sixin et al.. Pharmacological researches on Daphnetin. Chinese Herbal Medicine Study. 1977;8(3):21.Google Scholar
  4. 4.
    Plant groups from Traditional Chinese medicine research laboratory, Jilin institute of Chinese medicine. Study of Pharmacological effects on Daphnetin. New Med J.1977;(3):142.Google Scholar
  5. 5.
    Hong L, Weiping L, Xi L, et al. Effect to hemorheology induced by daphnetin and its derivative on type 2 diabetic rats. Jilin Med J. 2010;31(22):3614–6.Google Scholar
  6. 6.
    Xiulian J, Shuyan Q, Pan G, et al. The inhibition of daphnetin on central nervous system. Chin J ChiniseMeteria Med. 1986;11(3):Cover 2.Google Scholar
  7. 7.
    Fang H, Tan L. Screening antimalarial activity of daphnetin derivatives and research on their molecular targets. Int J Med Parasit Dis. 2008;35(6):303–4.Google Scholar
  8. 8.
    Shuyan Q, Yingjie M, Wang Y, et al. Metabolism and pharmacokinetics study of daphnetin. Acta Pharm Sin. 1983;18(7):496–500.Google Scholar
  9. 9.
    Ying J, Yu F. The influence of different transporters on the oral absorption of daphnetin using Caco – 2 cell model. Pharmacol Clin Chin Mater Med. 2012;28(1):52–6.Google Scholar
  10. 10.
    Liang SC, Ge GB, Xia YL, et al. In vitro evaluation of the effect of 7-methyl substitution on glucuronidation of daphnetin: metabolic stability, isoform selectivity, and bioactivity analysis. J Pharm Sci. 2015;104(10):2188–209.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China 2018

Authors and Affiliations

  1. 1.Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Centre for Pharmaceutical Screening, Institute of Materia MedicaChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina

Personalised recommendations